Skip to content
Scleroderma News logo
  • About scleroderma
    What is scleroderma?
    Causes
    Types
    Diagnosis
    • Skin biopsy
    Symptoms
    Scleroderma-related conditions
    Living with scleroderma
    • Pregnancy
    • Sexual health and dysfunction
  • Treatments
    Approved treatments
    Experimental treatments
    Non-drug treatments
    • Physical therapy
    • Phototherapy
  • News
  • Columns
    Scleroderma: Road Under Construction – Tomisa Starr
    Archived columns
    • Truth Be Told – Sherlene Perkins
    • Chronically Me — Amy Baker
    • Finding Strength — Lisa Weber
    • Scleroderma and the Ordinary Girl — Kim Tocker
    • Skintight — Dinah Chong Watkins
    • Staying Alive With Scleroderma — Amy Gietzen
  • What can we help you find today?

  • Social Clips
  • Last Week’s Top 3 Most Read Posts About Scleroderma

Last Week’s Top 3 Most Read Posts About Scleroderma

admin avatar

by admin | December 21, 2015

Share this article:

Share article via email

news_8-04

Read the Articles Here:

Systemic Sclerosis Patients Likely to Develop Micronutrient Deficiencies

Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria

New Biomarker Assay to Aid in Systemic Sclerosis Diagnosis

Print This Page

Tags

biomarker, diagnosis, Inflammatory Bacteria, Intestinal Microbiome, micronutrient deficiency, most read, top 3

Recent Posts

  • Clumps of modified stem cells seen to ease skin, lung scarring in mice
  • Efzofitimod found safe, well tolerated in study of SSc-ILD
  • Study shows immune signaling protein IL-40 is also involved in SSc
  • First SSc patient dosed in Phase 1 trial of CAR T-cell therapy
  • National Scleroderma Foundation recognizes outstanding chapters
  • Developing a plan is helpful when dealing with medical uncertainty
  • SRF joins capital effort to advance drug development for scleroderma
  • Scientists ID 4 SSc-ILD subtypes to better predict patient outcomes
  • Phase 2 trial testing nemolizumab for SSc slated to launch soon
  • Immune cells linked to kidney, lung complications in SSc: Study


Recommended reading

An oversized red pen ticks off boxes labeled
August 12, 2025 News by Marisa Wexler, MS

Efzofitimod found safe, well tolerated in study of SSc-ILD

An illustration of vials and a dropper with blood.
August 5, 2025 News by Steve Bryson, PhD

Study shows immune signaling protein IL-40 is also involved in SSc

A person wearing a baseball cap speaks with a megaphone in this announcement illustration.
July 29, 2025 News by Andrea Lobo, PhD

First SSc patient dosed in Phase 1 trial of CAR T-cell therapy

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.